You are here

home  ›  bio asia 2024

TRI: Leading the way
in Australasia

 


 

With Australia’s life sciences sector valued at over A$250 billion and recognised as one of the largest in the southern hemisphere, there are many advantages to choosing TRI and Queensland as a base for your research and development.

  • Strong reputation and rigorous regulatory standards and traceability of ingredients
  • Australian Government research and development tax incentives and over $20 billion in life sciences business support funding
  • Rapid ethics approvals via the Therapeutic Goods Administration (TGA) regulatory pathway, and established partnerships with major overseas regulators for easy scaling to global markets
  • Robust IP security and up to 25 years of patent protection
  • Fast growing hub for training of industry-ready scientists

*Austrade, Advanced Therapeutics in Australia 2023

 
Descriptive Alt Text
 

One of the largest translational research institutes in the southern hemisphere

 















For more than a decade, TRI has been welcoming researchers and organisations seeking to accelerate small-scale manufacturing of medical technology and pharmaceutical products for early-stage clinicial trials. Our unique, collaborative ecosystem supports the translation of research to commercial products. 

  
 


Seamlessly advancing medical discoveries to healthcare solutions

World-class laboratory and clinical translational research facilities
Company incubator, co-working, collaborative and educational spaces
GMP cleanroom infrastructure and regulatory compliance for small-scale manufacturing
Dedicated clinical trial facilities catering to adult and child participants
 
 

Manufacture at scale in Australia

 
 
Descriptive Alt Text
First Image Description Second Image Description

Due to open in 2025, TRI’s Translational Manufacturing facility will provide the necessary infrastructure to enable medtech and biotech businesses to expand and manufacture at scale on Australian shores. Combined with Queensland Government incentives, it will attract a range of industry, from local start-ups and SMEs to international biomedical corporations, delivering the first Australian facility to provide open access GMP production facilities.

TM@TRI is proudly funded by the Queensland Government and TRI.

 
 
Icon 1

Australian first
The only facility of its kind servicing the medtech and biotech sectors

Icon 2

Early-stage Clinical Trials
Onshore accelerated translation of new medicines, diagnostics and devices

Icon 3

Open to all
Welcoming TRI partners and external researchers

Icon 3

GMP
Good Manufacturing Practice compliance and onsite training 

Icon 3

Know-how
Infrastructure and processes managed by experienced GMP and quality staff 

 
 
 
 
 
 

In October 2023 more than 80 national and international AusBiotech delegates visited TRI as part of a Boggo Road Innovation Precinct tour. Join them as they explore TRI’s world-class facilities and get a sneak preview of our Translational Manufacturing @TRI site, designed to accommodate biotech companies wanting to scale up right here in Queensland. Opening in 2025, this new state-of-the-art manufacturing facility will provide infrastructure, support and services, and make TRI the only facility of its kind in Australia.

 
 
Descriptive Alt Text Take a Tour
 
 
 
First Logo


Exceptional Science. Healthier Lives.

Second Logo

To find out more about Team Queensland's presence at the Asia Bio Partnering Forum, click here.